CareCloud Inc reported second-quarter fiscal year 2026 revenue of $31.9 million, marking a 16% increase from $27.4 million in the prior-year period. The healthcare technology provider also recorded its ninth consecutive quarter of positive GAAP net income, reinforcing its operational stability amid strategic expansions.

The company completed the full redemption of its Series B preferred stock on May 15, 2026, funded by a new $50 million credit facility. This move eliminates approximately $3.3 million in annual preferred dividends, simplifying the capital structure and directing more net income toward common shareholders. Additionally, CareCloud entered the healthcare compliance market through the acquisition of Empower Healthcare and Compliance Partners, aiming to integrate AI-driven audit defense solutions into its platform.

Financial Performance Overview

Revenue growth was primarily driven by the MedSphere acquisition and a shift toward recurring revenue models. Recurring, technology-enabled business solutions accounted for approximately 75% of total revenue this quarter, up from 69% a year ago. While top-line growth remained robust, bottom-line metrics faced pressure from increased investment in AI development and integration costs.

GAAP net income declined to $1.1 million from $2.9 million in the same quarter last year. Management attributed this decrease to higher amortization expenses from recent acquisitions, increased research and development costs for AI initiatives, and new interest expense associated with the credit facility used to redeem preferred stock. Adjusted EBITDA stood at $5.9 million, while free cash flow generation improved slightly to $5.7 million.

Strategic Initiatives and Guidance

CareCloud reaffirmed its full-year 2026 guidance, projecting revenue between $128 million and $132 million, with adjusted EBITDA expected between $29 million and $31 million. The company anticipates stronger financial performance in the second half of the fiscal year as integration efforts conclude and AI products scale.

Key strategic developments include:

• Acquisition of Empower Healthcare to offer compliance and audit defense services.
• Launch of AI-enabled compliance software solutions planned for fall 2026.
• Consolidation of multiple platforms into a single modular system to enhance efficiency.

What the Numbers Show

A divergence exists between revenue momentum and profitability metrics. While revenue grew 16% YoY, GAAP net income fell 62% YoY. This gap is explained by the company’s deliberate trade-off: near-term earnings are being reinvested into R&D (which more than doubled) and acquisition-related amortization. However, free cash flow remained resilient at $5.7 million, indicating that the core recurring revenue model continues to generate cash despite accounting charges related to growth investments.